Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE: 603858)
Health Care · Pharmaceuticals · CN
CN¥15.52
-2.45% today · -18.5% 1Y
Shandong Buchang Pharmaceuticals Co., Ltd. (SHSE: 603858) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.43B and employs 7,237 people.
Over the last twelve months the share price has lost 18.5%, trading between 14.01 and 20.58.
Tweenvest scores Shandong Buchang Pharmaceuticals Co., Ltd. across four factors: quality 70/100, value 36/100, growth 0/100, dividend 85/100. Its strongest factor is dividend.
603858 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.43B
- Revenue (TTM)
- $1.69B
- P/E
- 43.76
- EPS
- 0.35
- Dividend yield
- 3.67%
- Beta (5Y)
- 0.30
- 52-week high
- CN¥20.58
- 52-week low
- CN¥14.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.05B
- Employees
- 7,237
- Next earnings
- —
About Shandong Buchang Pharmaceuticals Co., Ltd.
Shandong Buchang Pharmaceuticals Co., Ltd. is actively involved in China's pharmaceutical sector, specializing in the innovation, production, and distribution of medicinal products. The company provides a diverse range of treatments addressing various health conditions, including cardiovascular, cerebrovascular, urinary, digestive, and respiratory disorders, alongside gynecological problems and diabetes. Founded in 1993, this enterprise maintains its headquarters in Heze, China. Notably, it once operated as a subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.
- ISIN
- CNE100002FV6
- Founded
- 1993
- Listed since
- Nov 18, 2016
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,249.17 | -0.50% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.98 | +1.01% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.50 | -1.35% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.05 | -0.09% |
Figures last refreshed Aug 18, 2026.